Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming-Reference-Cited by-同舟云学术

Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming

Published:2018-08 Issue:6 Volume:24 Page:1496-1511.e8
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Ward Carl,Volpe Giacomo,Cauchy Pierre,Ptasinska Anetta,Almaghrabi Ruba,Blakemore Daniel,Nafria Monica,Kestner Doris,Frampton Jon,Murphy George,Buganim Yosef,Kaji Keisuke,García Paloma

Funder

MRC Research Capacity Building PhD studentship

MRC Centre for Regenerative Medicine

Wellcome Trust Institutional Strategic Support Fund (ISSF) mobility training grant

Wellcome Trust ISSF grant

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference61 articles.

1. Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector;Addis;PLoS One,2011

2. Disruption of B-myb in DT40 cells reveals novel function for B-Myb in the response to DNA-damage;Ahlbory;Oncogene,2005

3. Induced pluripotent stem cells and senescence: learning the biology to improve the technology;Banito;EMBO Rep.,2010

4. Extensive nuclear reprogramming underlies lineage conversion into functional trophoblast stem-like cells;Benchetrit;Cell Stem Cell,2015

5. Integration of kinase and calcium signaling at the level of chromatin underlies inducible gene activation in T cells;Brignall;J. Immunol.,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer;Cancer Research Communications;2024-09-01

2. A cochlear progenitor pool influences patterning of the mammalian sensory epithelium via MYBL2;Development;2024-09-01

3. Ectopic MYBL2-Mediated Regulation of Androglobin Gene Expression;Cells;2024-05-11

4. Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC;Hepatology;2024-03-27

5. MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer;2024-02-02